ROSENWALD LINDSAY A MD — SEC Form 4 filings
SEC reporting owner CIK 941841. 19 Form 4 filings on record with FilingPulse; latest filed 2026-06-26.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-01-09 to 2026-06-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 9 legs across 9 filings — 888,359 shares, $1,783,217 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: purchase of 763,359 shares @ $1.84 ($1,404,581) in Fortress Biotech, Inc., filed 2024-09-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | PRESIDENT, CEO & CHAIRMAN, Director, 10% owner | 9 | 7 legs · 858,359 sh · $1,684,817 | — | 3 |
| Journey Medical Corp (DERM) | Director | 6 | 2 legs · 30,000 sh · $98,400 | — | 4 |
| Checkpoint Therapeutics, Inc. (CKPT) | Director | 3 | — | — | 6 |
| AVENUE THERAPEUTICS, INC. (ATXI) | Director | 1 | — | — | 1 |
Form 4 filings — ROSENWALD LINDSAY A MD
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-26 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2026-03-20 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 475,424 @ $0 | EDGAR |
| 2025-08-07 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-07-07 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 7,173 @ $0 | EDGAR |
| 2025-05-30 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 12,195 @ $0 · Grant/award (A): 50,000 @ $1.29 · Code (U): 207,007 | EDGAR |
| 2025-01-03 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 454,153 @ $0 | EDGAR |
| 2024-12-17 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 12,638 @ $0 | EDGAR |
| 2024-09-25 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 763,359 @ $1.84 · Purchase (P): 763,359 (derivative) @ $0.12 | EDGAR |
| 2024-09-25 | 4 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 5,000 @ $7.48 | EDGAR |
| 2024-07-11 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 5,000 @ $7.39 | EDGAR |
| 2024-07-10 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 5,000 @ $7.35 | EDGAR |
| 2024-07-10 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 9,728 @ $0 | EDGAR |
| 2024-07-01 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 20,000 @ $1.64 | EDGAR |
| 2024-05-20 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 10,000 @ $1.76 | EDGAR |
| 2024-05-16 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 32,051 @ $0 · Grant/award (A): 50,000 @ $0 | EDGAR |
| 2024-03-27 | 4 | Journey Medical Corp (DERM) | Purchase (P): 10,000 @ $3.04 | EDGAR |
| 2024-03-25 | 4 | Journey Medical Corp (DERM) | Purchase (P): 20,000 @ $3.40 | EDGAR |
| 2024-01-09 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 50,000 @ $2.38 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=941841 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →